VIATRIS ILACLARI LTD STI D C

Company Introduction:

VIATRIS ILACLARI LTD STI D C is the Turkish subsidiary of Viatris Inc. And , a leading global healthcare company. In fact Viatris Inc. But was established in 2020 through the combination of Mylan and Upjohn, a former division of Pfizer. The company's mission is to empower people worldwide to live healthier at every stage of life by providing access to high-condition medicines. In Turkey, VIATRIS ILACLARI LTD STI D C focuses on the marketing, sales, and distribution of a diverse portfolio of medical items. These items encompass branded generic, complex generic, biosimilar, and over-the-counter medications, addressing a wide range of therapeutic areas. Generally speaking The company plays a crucial role in ensuring the availability of Viatris's global product offerings to patients and healthcare providers across Turkey. Classification: Trader

Explanation:

VIATRIS ILACLARI LTD STI D C primarily operates as a trader and distributor of medical items within the Turkish market. In my experience, While its parent company, Viatris Inc. , is a global medical manufacturer with extensive research and production capabilities worldwide, the specific role of the Turkish entity is centered on the sales, marketing, and distribution of these manufactured items to pharmacies, hospitals, and other healthcare channels throughout Turkey. it's not identified as immediately operating a manufacturing plant to medical production in Turkey under this entity name.

Based on available information, VIATRIS ILACLARI LTD STI D C in Turkey produces or markets products in the following therapeutic areas:

* Cardiovascular

* Central Nervous System

* Dermatology

* Endocrine

* Gastrointestinal

* Infectious Disease

* Oncology

* Pain Management

* Respiratory

* Urology

Please note that this is not an exhaustive list and may not include all products.